Javascript must be enabled to continue!
Fetal growth in PCOS pregnancies: dynamic evidence of restriction and the modifying role of ART
View through CrossRef
Background
Polycystic ovary syndrome (PCOS), the most prevalent endocrine disorder among women of reproductive age, is associated with adverse pregnancy outcomes. However, the dynamic trajectory of fetal growth in PCOS pregnancies remains inadequately characterized.
Objective
This study aimed to longitudinally assess fetal growth in PCOS pregnancies and evaluate whether assisted reproductive technology (ART) modifies associated fetal growth restriction.
Methods
In this prospective multicenter cohort study (UNIHOPE; NCT03220750), 12,189 advanced maternal age pregnancies (364 with Rotterdam-diagnosed PCOS) underwent longitudinal fetal biometry in the second and third trimesters following ISUOG guidelines. Z-scores were derived using the study’s advanced-age reference, adjusting for gestational age and sex. Generalized linear models were adjusted for maternal demographics, lifestyle factors, and gestational diabetes mellitus, with subgroup analyses stratified by ART conception.
Results
Among 12,189 advanced maternal age pregnancies (364 PCOS), PCOS fetuses showed reduced second-trimester Z-scores for femur length (MD: −0.13; 95% CI, −0.25 to −0.02) and head circumference (MD: −0.14; 95% CI, −0.23 to −0.04), with third-trimester deficits extending to biparietal diameter (MD: −0.18) and abdominal circumference (MD: −0.16). Birth length (MD: −0.16) and weight (MD: −0.13) Z-scores were lower in PCOS neonates. Growth restriction was evident only in spontaneous conceptions, with no significant differences in ART-conceived pregnancies. Findings were robust to GDM adjustment.
Discussion
Fetal growth restriction in PCOS pregnancies is detectable from the second trimester and persists to delivery. ART conception appears to mitigate this restriction, yielding fetal growth parameters comparable to the reference population. These findings underscore the necessity of dynamic ultrasound surveillance in PCOS pregnancies and highlight a potential protective role of ART in perinatal outcomes.
Clinical trial registration
https://clinicaltrials.gov
, identifier NCT03220750.
Title: Fetal growth in PCOS pregnancies: dynamic evidence of restriction and the modifying role of ART
Description:
Background
Polycystic ovary syndrome (PCOS), the most prevalent endocrine disorder among women of reproductive age, is associated with adverse pregnancy outcomes.
However, the dynamic trajectory of fetal growth in PCOS pregnancies remains inadequately characterized.
Objective
This study aimed to longitudinally assess fetal growth in PCOS pregnancies and evaluate whether assisted reproductive technology (ART) modifies associated fetal growth restriction.
Methods
In this prospective multicenter cohort study (UNIHOPE; NCT03220750), 12,189 advanced maternal age pregnancies (364 with Rotterdam-diagnosed PCOS) underwent longitudinal fetal biometry in the second and third trimesters following ISUOG guidelines.
Z-scores were derived using the study’s advanced-age reference, adjusting for gestational age and sex.
Generalized linear models were adjusted for maternal demographics, lifestyle factors, and gestational diabetes mellitus, with subgroup analyses stratified by ART conception.
Results
Among 12,189 advanced maternal age pregnancies (364 PCOS), PCOS fetuses showed reduced second-trimester Z-scores for femur length (MD: −0.
13; 95% CI, −0.
25 to −0.
02) and head circumference (MD: −0.
14; 95% CI, −0.
23 to −0.
04), with third-trimester deficits extending to biparietal diameter (MD: −0.
18) and abdominal circumference (MD: −0.
16).
Birth length (MD: −0.
16) and weight (MD: −0.
13) Z-scores were lower in PCOS neonates.
Growth restriction was evident only in spontaneous conceptions, with no significant differences in ART-conceived pregnancies.
Findings were robust to GDM adjustment.
Discussion
Fetal growth restriction in PCOS pregnancies is detectable from the second trimester and persists to delivery.
ART conception appears to mitigate this restriction, yielding fetal growth parameters comparable to the reference population.
These findings underscore the necessity of dynamic ultrasound surveillance in PCOS pregnancies and highlight a potential protective role of ART in perinatal outcomes.
Clinical trial registration
https://clinicaltrials.
gov
, identifier NCT03220750.
Related Results
O-105 Chromatin accessibility of oocytes contributes to PCOS transgenerational inheritance
O-105 Chromatin accessibility of oocytes contributes to PCOS transgenerational inheritance
Abstract
Study question
What is the underlying mechanism contributing to the transgenerational defects of oocytes and embryos of...
INVESTIGATING CARDIOVASCULAR AND METABOLIC HEALTH PROFILES IN WOMEN WITH AND WITHOUT POLYCYSTIC OVARY SYNDROME: INSIGHTS FROM DISTRICT GHOTKI
INVESTIGATING CARDIOVASCULAR AND METABOLIC HEALTH PROFILES IN WOMEN WITH AND WITHOUT POLYCYSTIC OVARY SYNDROME: INSIGHTS FROM DISTRICT GHOTKI
Background: Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder that impacts women’s reproductive and metabolic health. PCOS is frequently associated with increased ...
P-326 No higher incidence of chronic endometritis in infertile women with polycystic ovary syndrome: a propensity score-matched study
P-326 No higher incidence of chronic endometritis in infertile women with polycystic ovary syndrome: a propensity score-matched study
Abstract
Study question
Do infertile women with polycystic ovary syndrome(PCOS) have a higher incidence of chronic endometritis(...
Phenotypic Variation in Hyperandrogenic Women Influences the Findings of Abnormal Metabolic and Cardiovascular Risk Parameters
Phenotypic Variation in Hyperandrogenic Women Influences the Findings of Abnormal Metabolic and Cardiovascular Risk Parameters
In hyperandrogenic women, several phenotypes may be observed. This includes women with classic polycystic ovary syndrome (C-PCOS), those with ovulatory (OV) PCOS, and women with id...
Not just a barrier : deciphering molecular and cellular signatures of placental villi in health and endocrine diseases
Not just a barrier : deciphering molecular and cellular signatures of placental villi in health and endocrine diseases
<p dir="ltr">Maternal obesity, intermediate hyperglycaemia, and PCOS can disrupt placental transport, endocrine, and immune functions, increasing the risk of adverse pregnanc...
Not just a barrier : deciphering molecular and cellular signatures of placental villi in health and endocrine diseases
Not just a barrier : deciphering molecular and cellular signatures of placental villi in health and endocrine diseases
<p dir="ltr">Maternal obesity, intermediate hyperglycaemia, and PCOS can disrupt placental transport, endocrine, and immune functions, increasing the risk of adverse pregnanc...
SAT-137 PCOS: From Ovaries to Arteries - An Evolving Recognition of Vascular Risk for Women
SAT-137 PCOS: From Ovaries to Arteries - An Evolving Recognition of Vascular Risk for Women
Abstract
Disclosure: R. Trivedi: None. S. Chrysafides: None. N. Rahman: None. A. Lim: None. A.F. Firek: None. I. Munir: None. A. Yang: None. M. Firek: None.
...
The effect of human menstrual blood-derived stem cells on ovarian folliculogenesis, angiogenesis and collagen volume in female rats affected by the polycystic ovary syndrome
The effect of human menstrual blood-derived stem cells on ovarian folliculogenesis, angiogenesis and collagen volume in female rats affected by the polycystic ovary syndrome
Abstract
Background: Infertility is one of the common problems among couples, affecting millions of people worldwide. Polycystic ovary syndrome(PCOS) is one of the main cau...

